StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

AXIM Biotechnologies's price to sales ratio was 9.7× on Oct 19, 2026, against 31.7× a year earlier. Over the last 5 years it ranged from 6.0× to 498.7×, with a median of 45.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20269.7×−24.2
2025Dec 31, 202533.9×+27.9
2024Dec 31, 20246.0×−125.0
2023Dec 29, 2023131.0×−86.9
2022Jul 29, 2022217.9×+152.1
2021Jan 29, 202165.8×−2.0
2020Dec 31, 202067.8×−56.7
2019Dec 31, 2019124.5×−29.9
2016Sep 30, 2016154.4×−195.8
2015Dec 31, 2015350.2×–

More AXIM Biotechnologies figures

See a number that looks wrong?